Safety of MDMA in people with moderate liver damage
This trial is testing the safety of MDMA (the drug in ecstasy) in people with moderate liver damage compared to healthy volunteers. The goal is to see how the body processes MDMA when the liver isn't working perfectly, so doctors can find the right dose and avoid harm.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 65 years old.
- You must have either moderate liver damage (Child-Pugh class B) or normal liver function.
- You must weigh more than 45 kg (about 99 pounds).
- You must not have a current psychiatric diagnosis.
- You must be willing to stay in the clinical unit for the required time.
- You must have a negative alcohol and drug test before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study looks at whether MDMA is tolerable (safe enough) in people diagnosed with schizophrenia. Researchers will check safety while you stay stable on your usual care.
This trial tests different doses of MDMA (a drug sometimes called 'ecstasy') combined with therapy to see which dose works best for treating PTSD in veterans. The goal is to find a safer, more effective dose to help reduce PTSD symptoms.
This trial tests if MDMA-assisted therapy can help mental healthcare providers. It involves taking MDMA in a therapeutic setting while being recorded, and you must be trained in this type of therapy.
This study tests a new medicine (MDR-001) in people with mild to moderate liver problems to see how the body processes it and if it's safe. It may help doctors find the right dose for patients with liver disease.
This trial tests how the body processes ammoxetine in people with mild or moderate liver impairment compared to people with normal liver function. It aims to find out if the drug is safe and how it works in these groups.
This trial tests if a single dose of MDMA can reduce pain caused by heat or pressure in healthy volunteers. It aims to see if MDMA might help with certain types of pain that are hard to treat.
Hear when a new Hepatic Impairment trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.